REGN
How Apogee, Up 14%, Plans To Take On Rival Regeneron's Eczema Drug
Apogee Therapeutics reported a "best case scenario" Monday for its potential rival to eczema drug, Dupixent.
Investor's Business Daily  ·  Mar 23, 2026 READ →
PLTR
FTSE 100 Live: Shares whipsaw on Trump's Iran talks claim, denied by Tehran
FTSE 100 rises 44 points to 9,962 US and Iran held 'successful' peace talks, Trump claims Iran says 'no direct communications' made Oil prices fall, gold and silver erase losses UK government borrowing costs earlier hit 2008 high 1.57pm: Wall Street opens in risk-on mode US...
Proactive  ·  Mar 23, 2026 READ →
PFE
Mixed results for Lyme disease vaccine hit Valneva shares
An experimental vaccine for Lyme disease is broadly effective, pharmaceutical companies Pfizer and Valneva announced Monday, however the latter firm's shares fell because the clinical trial did not reach its main goal.The new vaccine candidate "demonstrated more than 70 percent efficacy in preventing Lyme disease in individuals aged five years and above" during a phase 3 clinical trial, the US and French-Austrian companies said in a joint statement. 
AFP  ·  Mar 23, 2026 READ →
TSLA
Long-time Tesla bull flips to sell, sees stock plunging to $150 amid AI concerns
Chowdhry drew a dramatic comparison to 3D Systems Corporation (NYSE:DDD), which he claims his firm Global Equities Research correctly predicted would collapse from its $84 peak in 2013 to its current price of $1.93. "TSLA/xAi Story based investment thesis is over," Chowdhry wrote in a note to clients, adding that "waiting for TSLA/xAI to come up with their next story for Stock to move up is utterly foolish."
Investing.com  ·  Mar 23, 2026 READ →
SPG
David Simon, Mall King Who Was Both Feared and Admired, Dies at 64
David Simon, whose ruthless negotiating tactics, obsession with details and sheer force of will turned his family’s real-estate business into the largest mall owner in the country, died Sunday after a cancer diagnosis in 2024. During his more than three decades as Simon Property Group’s chief executive, the inveterate dealmaker gobbled up competitors and defied critics, who said malls were obsolete. The Simon family through a charitable foundation donates to many causes, including a $5 million gift to Columbia University.
The Wall Street Journal  ·  Mar 23, 2026 READ →
AAPL
Apple Gains on Strong iPhone Upgrade Trends
Survey points to rising demand, higher upgrade rates, and market share gains
GuruFocus.com  ·  Mar 23, 2026 READ →
INTC
If You Invested $10,000 in Mastercard Stock 10 Years Ago, Here's How Much You'd Have Today
This top payments platform, which has a global presence, has done a nice job rewarding its patient investors.
Motley Fool  ·  Mar 23, 2026 READ →
V
If You Invested $10,000 in Mastercard Stock 10 Years Ago, Here's How Much You'd Have Today
This top payments platform, which has a global presence, has done a nice job rewarding its patient investors.
Motley Fool  ·  Mar 23, 2026 READ →
NVDA
If You Invested $10,000 in Mastercard Stock 10 Years Ago, Here's How Much You'd Have Today
This top payments platform, which has a global presence, has done a nice job rewarding its patient investors.
Motley Fool  ·  Mar 23, 2026 READ →
AVGO
Chip Stocks Pop as Trump Hits Pause on Iran Strikes
Nvidia, AMD Surge After Trump Signals Middle East Cease-Fire Breakthrough
GuruFocus.com  ·  Mar 23, 2026 READ →
PLTR
Chip Stocks Pop as Trump Hits Pause on Iran Strikes
Nvidia, AMD Surge After Trump Signals Middle East Cease-Fire Breakthrough
GuruFocus.com  ·  Mar 23, 2026 READ →
INTC
Chip Stocks Pop as Trump Hits Pause on Iran Strikes
Nvidia, AMD Surge After Trump Signals Middle East Cease-Fire Breakthrough
GuruFocus.com  ·  Mar 23, 2026 READ →